Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease

Maria Ayub, Hee Kyung Jin, Jae sung Bae

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The majority of peripheral and central nervous system disorders are related to hyperactive inflammatory responses, leading to irreversible and persistent cellular defects, functional impairments, and behavioral deficits. Advances in our understanding of these disorders have revealed the disruption of inflammation resolution pathways due to abrogated responses by specialized pro-resolving lipid mediators (SPMs). SPMs comprise a class of bioactive lipids and cell signaling molecules that function to resolve inflammation, pain, and function in host defense and tissue remodeling. Their cellular and systemic levels during physiology and pathology are regulated by sphingosine kinases (especially SphK1) that act by monitoring cyclooxygenase-2 (COX2), a potent inhibitor of SPMs production. This review presents the current understanding of the convergent mechanisms shared by bioactive lipids with SphK1 and COX2 in the etiology of chronic inflammatory disorders, focusing on neuroinflammation, as well as describes the translational directions of this trilogy for the treatment of Alzheimer's disease.

Original languageEnglish
Article number159126
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Issue number5
StatePublished - May 2022
Externally publishedYes


  • Alzheimer's disease
  • COX2
  • Inflammation
  • Lipid mediators
  • Sphingosine kinase 1


Dive into the research topics of 'Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this